journal article·2019-12-04Open access

PTEN negatively regulates the expression of pro-inflammatory cytokines and chemokines of fibroblast-like synoviocytes in adjuvant-induced arthritis

Xiao-Feng Li, Xin Chen, Jing Bao, Le Xu, Lei Zhang, Cheng Huang, Xiao-Ming Meng, Jun Li

Abstract

Rheumatoid arthritis (RA) is characterized by tumor-like expansion of the synovium and the subsequent destruction of adjacent articular cartilage and bone. The latest studies proved phosphatase and tension homolog deleted on chromosome 10 (PTEN) might contribute to the surviving, proliferation and pro-inflammatory cytokines in RA. The purpose of this study was to explore the function and underlying mechanisms of PTEN in RA pro-inflammatory cytokines and chemokines of fibroblast-like synoviocytes (FLSs). Increased level of PTEN was observed in adjuvant-induced arthritis (AIA) FLSs in comparison to normal rats. Increased concentrations of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β), chemokines (CCL-2 and CCL-3), VCAM-1 and VEGF-α expression were observed in FLSs with PTEN inhibitor bpv or PTEN-RNAi. Moreover, co-incubation FLSs with overexpression vector with PTEN-GV141 reduced the expression of pro-inflammatory cytokines, chemokines, VCAM-1 and VEGF-α in AIA. Interestingly, we also found DNA methylation could regulate PTEN expression and activation of AKT signaling was with a change of PTEN. Altogether, our findings in the present study suggested that PTEN might play a pivotal role during pro-inflammatory cytokines and chemokines of FLSs through activation of AKT signaling pathway. In addition, PTEN expression may be regulated by DNA methylation in the pathogenesis of AIA.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: PI3K/AKT/mTOR signaling in cancer · Quinazolinone synthesis and applications · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University

The Key Laboratory of Anti-Inflammatory and Immune Medicines, Ministry of Education

Hematology Department, First Affiliated Hospital of Anhui Medical University

Departments of Stomatology, Fourth Affiliated Hospital of Anhui Medical University

Funding

National Natural Science Foundation of China

References (38)

Show source-provided references
1. 10.1016/S0092-8674(00)81109-510.1016/S0092-8674(00)81109-5 ↗
2. 10.1111/j.1600-065X.2008.00648.x10.1111/j.1600-065X.2008.00648.x ↗
3. 10.1007/s10456-015-9477-210.1007/s10456-015-9477-2 ↗
4. 10.1038/cddis.2016.49010.1038/cddis.2016.490 ↗
5. 10.1016/j.cyto.2017.05.00110.1016/j.cyto.2017.05.001 ↗
6. 10.1038/srep2005910.1038/srep20059 ↗
7. 10.1186/s13075-017-1472-010.1186/s13075-017-1472-0 ↗
8. 10.1038/s41598-017-12570-610.1038/s41598-017-12570-6 ↗
9. 10.1002/art.3799610.1002/art.37996 ↗
10. 10.1146/annurev.immunol.14.1.39710.1146/annurev.immunol.14.1.397 ↗
11. 10.1093/rheumatology/keh20110.1093/rheumatology/keh201 ↗
12. 10.1155/2017/689437410.1155/2017/6894374 ↗
13. 10.1016/j.semarthrit.2017.10.02210.1016/j.semarthrit.2017.10.022 ↗
14. 10.1093/rheumatology/kex33910.1093/rheumatology/kex339 ↗
15. 10.1002/art.4031910.1002/art.40319 ↗
16. 10.1002/art.4021810.1002/art.40218 ↗
17. 10.1038/s41598-017-00517-w10.1038/s41598-017-00517-w ↗
18. 10.1084/jem.2017052310.1084/jem.20170523 ↗
19. 10.1038/cmi.2017.3010.1038/cmi.2017.30 ↗
20. 10.1016/j.molimm.2015.07.03310.1016/j.molimm.2015.07.033 ↗
21. 10.1002/art.2351710.1002/art.23517 ↗
22. 10.1016/j.jbspin.2015.10.00710.1016/j.jbspin.2015.10.007 ↗
23. 10.1016/j.atherosclerosis.2017.09.03310.1016/j.atherosclerosis.2017.09.033 ↗
24. 10.1038/nrrheum.2016.9110.1038/nrrheum.2016.91 ↗
25. 10.1097/BOR.000000000000047010.1097/BOR.0000000000000470 ↗
26. 10.1136/ard.2005.04564110.1136/ard.2005.045641 ↗
27. McWilliams DF, Walsh DA. Pain mechanisms in rheumatoid arthritis. Clin Exp Rheumatol. 2017;35 Suppl 107(5):94–101.
28. 10.1002/art.2111810.1002/art.21118 ↗
29. 10.1111/j.0105-2896.2009.00854.x10.1111/j.0105-2896.2009.00854.x ↗
30. 10.1186/ar6910.1186/ar69 ↗
31. 10.2119/molmed.2010.0006710.2119/molmed.2010.00067 ↗
32. 10.1186/s13075-017-1337-610.1186/s13075-017-1337-6 ↗
33. 10.1016/j.ccr.2013.09.01410.1016/j.ccr.2013.09.014 ↗
34. 10.1016/j.cyto.2017.05.02310.1016/j.cyto.2017.05.023 ↗
35. 10.3892/etm.2015.263510.3892/etm.2015.2635 ↗
36. 10.1038/nature0875010.1038/nature08750 ↗
37. 10.1136/annrheumdis-2012-20152610.1136/annrheumdis-2012-201526 ↗
38. 10.1016/j.celrep.2014.08.02810.1016/j.celrep.2014.08.028 ↗